Wright Investors Service Inc. increased its stake in shares of Aetna Inc. (NYSE:AET) by 2.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 28,938 shares of the company’s stock after acquiring an additional 805 shares during the quarter. Aetna comprises about 1.7% of Wright Investors Service Inc.’s portfolio, making the stock its 10th largest holding. Wright Investors Service Inc.’s holdings in Aetna were worth $4,601,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. Bruderman Asset Management LLC bought a new position in shares of Aetna during the second quarter worth $106,000. Liberty Capital Management Inc. boosted its position in shares of Aetna by 206.9% during the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after acquiring an additional 629 shares during the last quarter. Westside Investment Management Inc. boosted its position in shares of Aetna by 53.5% during the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after acquiring an additional 400 shares during the last quarter. Phocas Financial Corp. bought a new position in shares of Aetna during the second quarter worth $182,000. Finally, Highstreet Asset Management Inc. boosted its position in shares of Aetna by 105.5% during the third quarter. Highstreet Asset Management Inc. now owns 1,243 shares of the company’s stock worth $198,000 after acquiring an additional 638 shares during the last quarter. Hedge funds and other institutional investors own 89.45% of the company’s stock.
Aetna Inc. (NYSE AET) traded up 0.57% during midday trading on Wednesday, hitting $171.00. 877,434 shares of the stock traded hands. The stock has a 50-day moving average of $159.75 and a 200 day moving average of $152.04. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $184.98. The firm has a market cap of $56.79 billion, a PE ratio of 37.96 and a beta of 0.53.
Aetna (NYSE:AET) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating the consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company’s revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.07 EPS. Equities analysts forecast that Aetna Inc. will post $9.50 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.18%. Aetna’s payout ratio is 43.67%.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
A number of brokerages recently weighed in on AET. Cantor Fitzgerald lowered shares of Aetna from an “overweight” rating to a “neutral” rating in a research report on Thursday, October 26th. BMO Capital Markets upped their target price on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Argus restated a “buy” rating and set a $185.00 target price (up previously from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. Finally, Royal Bank Of Canada increased their price objective on shares of Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a research report on Friday, August 4th. Nine equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. Aetna currently has an average rating of “Buy” and an average target price of $163.67.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.